Long-term outcome of myotonia associated with hyperadrenocorticism in 2 dogs.
Two dogs were diagnosed with myotonia associated with hyperadrenocorticism and treated with trilostane. One dog showed temporary improvement, but the other dog showed no improvement. The dogs survived 2383 and 1902 days, respectively. Findings suggest that myotonia persists despite treatment, but this condition is not associated with a poor prognosis for survival.
Yuki Animal Hospital, 2-99 Kiba-cho, Minato-ku, Nagoya, Aichi 455-0021, Japan.
Noriyuki
N
Nagata
Yuki Animal Hospital, 2-99 Kiba-cho, Minato-ku, Nagoya, Aichi 455-0021, Japan.
Masashi
M
Yuki
D000308:Adrenocortical Hyperfunction / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D000818:Animals; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004283:Dog Diseases / Q000209:etiology* / Q000473:pathology; D004285:Dogs; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D009135:Muscular Diseases / Q000209:etiology / Q000662:veterinary*
D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; C009954:trilostane